Gastrointestinal Cancer: Targets and Therapy is an open-access, peer-reviewed journal that focuses on publishing high-quality research, reviews, and expert opinions related to the treatment and management of gastrointestinal cancers. The journal addresses a wide array of topics. The first 150 characters are: An open-access journal focused on gastrointestinal cancer treatment and management, covering chemotherapy, surgery, radiation therapy, and targeted therapies.
Key areas include but are not limited to: the latest advances in chemotherapy, targeted therapies, surgical techniques, and radiation therapy for cancers of the esophagus, stomach, liver, pancreas, colon, and rectum. Gastrointestinal Cancer: Targets and Therapy aims to provide a platform for researchers and clinicians to share innovative findings that contribute to improved outcomes for patients with gastrointestinal malignancies. Indexed in major scientific databases, the journal targets a global audience of oncologists, surgeons, radiation therapists, and researchers specializing in gastrointestinal cancer.
With its open-access format, Gastrointestinal Cancer: Targets and Therapy ensures that its content is readily accessible to a broad readership. The journal encourages submissions that highlight novel therapeutic strategies, personalized medicine approaches, and advancements in the understanding of gastrointestinal cancer biology, promoting progress in the field.